Am I missing anything? Is this the right decision?

Is this a connection?

Are I too late?

Find clarity in your investment decision-making.

Manage your portfolio for sustainable growth and regulatory alignment

with the ultimate blend of powerful AI and

industry expertise.

Reduce risk, meet your sustainability goals and push the boundaries of possibilities based on

facts, not opinions.

Clarity AI scaling human decisions through tech.

Visit clarity.

AI and take action today. Hi, this is Behind the Money with the Financial Times. I'm Amy Keene.

This week on the podcast, we're looking at a company accused of fueling the opioid epidemic in the U.S.

In the last few years a series of exposés have connected the philanthropic Sackler

families billions to sales of OxyContin Maker Purdue Pharma.

And while more than a thousand lawsuits from cities and states across the country have accused the company of

deceptively marketing the prescription painkiller, a new case is targeting members of the family

itself.

So how did the drugmaker fuel the market for opioids? So you have to go back a long time to when the three original Sackler brothers were alive,

Arthur Raymond and Mortimer. They had a British company called

NAP Pharmaceuticals and scientists there happened upon a new sort of type of pill which could sort of kind of think about it like

dripping the drug into the body over a very long period of time.

...